SERPINA1 and chronic obstructive pulmonary disease: Although we cannot quantitatively establish that RBPs or changes in cell type population alone are responsible for the observed difference in the distal ratio of SERPINA1 mRNA in COPD lungs (Fig 2B, 2C and 2D), our data reveal the complex network of factors that ultimately control A1AT protein production at the molecular and cellular level in the lung.